Search results
Dec 11, 2020 · The Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to: prevent COVID-19 in individuals 12 years of age and older, and. provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise.
This article provides a summary of the interim recommendations for the use of the Pfizer BioNTech (BNT162b2) vaccine against COVID-19 issued by WHO Strategic Advisory Group of Experts on Immunization (SAGE).
Medical uses. The Pfizer–BioNTech COVID-19 vaccine is used to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus, by eliciting an immune response to the S antigen. [1] [2] [30] [39] The vaccine is used to reduce morbidity and mortality from COVID-19.
Sep 11, 2023 · The Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19. The Pfizer-BioNTech...
Shortly after on December 11, 2020, the U.S. Food and Drug Administration (FDA) authorized the Pfizer-BioNTech COVID-19 Vaccine for emergency use. A mere 13 months after trial initiation, the vaccine became the first FDA approved COVID-19 vaccine on August 23, 2021.
Oct 21, 2021 · First results from any randomized, controlled COVID-19 vaccine booster trial demonstrate a relative vaccine efficacy of 95.6% against disease during a period when Delta was the prevalent strain. In trial with more than 10,000 participants 16 years of age and older, COVID-19 booster was found to have a favorable safety profile.
Aug 23, 2021 · FDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19...
A clinical trial demonstrated that the vaccine has an efficacy rate of over 90 percent in preventing Covid-19. Producing a batch of the Pfizer-BioNTech vaccine currently takes 60 days.
Mar 26, 2022 · The Pfizer-BioNTech vaccine is the first mRNA-based vaccination that enhances immunity. Resulting in various adverse effects that may emerge after vaccination. This systematic review was undertaken to assess the Pfizer-BioNTech vaccine side effects by reviewing the previous studies.
Apr 19, 2024 · The Pfizer/BioNTech vaccine is the first COVID-19 vaccine authorized for use in the U.S. and the first to be fully approved by the FDA. The companies released promising interim results from...
